These CD38+ M-MDSCs possessed a greater capacity to suppress the T cell proliferation by a mixed lymphocyte reaction assay, which contributed to colorectal cancer (CRC) pathogenesis. The gene discussed is CD38; the disease is colorectal carcinoma.